Yifan Xu

180 Fenglin Road
Zhongshan, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Extracellular peroxiredoxin 6 released from alveolar epithelial cells as a DAMP drives macrophage activation and inflammatory exacerbation in acute lung injury.

Extracellular peroxiredoxin 6 released from alveolar epithelial cells as a DAMP drives macrophage activation and inflammatory exacerbation in acute lung injury.

Journal: International immunopharmacology

Published: November 15, 2024

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.

Journal: Journal of hematology & oncology

Published: August 15, 2022

Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.

Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.

Journal: Virchows Archiv : an international journal of pathology

Published: June 05, 2022

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.

PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma.

Journal: Frontiers in oncology

Published: March 16, 2022

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome.

CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome.

Journal: Frontiers in genetics

Published: October 11, 2020

Midostaurin potentiates rituximab antitumor activity in Burkitt's lymphoma by inducing apoptosis.

Midostaurin potentiates rituximab antitumor activity in Burkitt's lymphoma by inducing apoptosis.

Journal: Cell death & disease

Published: September 29, 2018

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.

Journal: Scientific reports

Published: December 05, 2016

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma.

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma.

Journal: Oncotarget

Published: November 14, 2016

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

Journal: Oncotarget

Published: October 17, 2016

Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.

Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.

Journal: Oncotarget

Published: August 15, 2016

Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.

Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 17, 2015

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.

Journal: BMC cancer

Published: February 05, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026